Meeting of Minds XIV
15 – 24 November 2022


This year’s Meeting of Minds is a series of 4 x 90-minute live broadcasts (webinars), for clinicians with an interest in ADHD in adults.
‘This meeting is initiated, organised and funded by Takeda’
For healthcare professionals only.

Register now

Meeting of Minds XIII
Now available on demand


Please register to view the speaker presentations and clinical hot topics from Meeting of Minds XIII,  9 – 25 November 2021
‘This meeting is initiated, organised and funded by Takeda’
For healthcare professionals only

Register now

ADHD can be a lifelong disorder


ADHD is a chronic neurodevelopmental disorder which can affect children, adolescents and adults

Read more

Assessment and diagnosis


ADHD assessment involves clinical examination, interviews and rating scales. Formal ADHD diagnosis typically utilises DSM-5TM or ICD-11 classification systems

Read more

Optimal management of ADHD


The optimal management of ADHD process should always consider input from the patient, family/caregivers and school to help establish an appropriate and extensive treatment programme (non-pharmacological and pharmacological therapy), goals and assessment/follow-up, resulting in a tailored multimodal treatment plan centred on the patient

Read more

Attention-deficit hyperactivity disorder (ADHD) is a diverse condition characterised by symptoms of inattention, hyperactivity and impulsivity; and can have a significant impact on patients’ lives.1,2 This website provides educational resources intended for healthcare professionals outside the US and UK with an interest in ADHD. It aims to share scientific advances in ADHD research and provide expert opinions and medical knowledge to support the healthcare professional community.

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. 2013.
  2. World Health Organization. ICD-11: International Classification of Diseases 11th Revision. 2018. Available at: https://icd.who.int. Accessed January 2021.
Filter content by:

Meeting of Minds XIII – Now available on demand

Please register to view the speaker presentations and clinical hot topics from Meeting of Minds XIII, 9 – 25 November 2021

Meeting of Minds XII, 27 October to 23 November 2020

Reports covering key ADHD topics discussed at Meeting of Minds XII are available now

33rd European Clinical Neuropsychopharmacology (ECNP) Virtual Congress

The 33rd European Clinical Neuropsychopharmacology Congress covered key topics and issues in ADHD

28th European Congress of Psychiatry (EPA) Virtual Congress

The 28th European Congress of Psychiatry in Madrid was transformed into a fully virtual meeting for 2020

eLearning: Rating Scales

An overview of rating scales used in the assessment of patients with ADHD

Animation: Adult ADHD and the brain

Animation: Childhood/Adolescent ADHD and treatment effects in the brain

Animation: Childhood/Adolescent ADHD and the brain

Are sex differences associated with substance use disorder in adolescents with ADHD?

Castellano-García F et al. Brain Sci 2022; 12(5): 590

30 May 2022

Psychiatric disorders associated with attentional problems

Grant JE, Chamberlain SR. CNS Spectr 2022; 1-4

23 May 2022

Treating ADHD in children: is neurofeedback training as effective as behavioural therapy and pharmacological treatment?

Roy S et al. Asian J Psychiatr 2022; 103133

17 May 2022

Late manifestation of ADHD in older adults

Sasaki H et al. BMC Psychiatry 2022; 22: 354

10 May 2022

Does the geographical variation in ADHD diagnoses reflect the level of symptoms in Norway?

Widding‑Havneraas T et al. Eur Child Adolesc Psychiatry 2022; Online ahead of print.

3 May 2022

Automated detection of ADHD: current trends and future perspective

Loh HW et al. Comput Biol Med 2022; 146: 105525

30 Apr 2022

Prevalence of ADHD in young people depending on race

Cénat JM et al. J Clin Child Adolesc Psychol 2022; Epub ahead of print

23 Apr 2022

Cannabis use in adults with ADHD: efficacy of CANreduce 2.0

Ahlers J et al. J Med Internet Res 2022; 24: e30138

16 Apr 2022


ADHD Institue logo

You’re now being transferred to

and are leaving the ADHD Institute site

Takeda has no influence or control over the content of this third party website.

Continue Cancel